Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Mohammad, Aladdin LU ; Hot, A ; Arndt, F ; Moosig, F ; Guerry, M-J ; Amudala, N ; Smith, R ; Sivasothy, P ; Guillevin, L and Merkel, P A , et al. (2016) In Annals of the Rheumatic Diseases 75(2). p.396-401
Abstract
Conventional treatment of eosinophilic granulomatosis with polyangiitis (EGPA) (Churg-Strauss) with glucocorticoids, with or without additional immunosuppressive drugs, is limited by partial efficacy, frequent toxicity and a high relapse rate. Rituximab is a licensed treatment for granulomatosis with polyangiitis and microscopic polyangiitis and is of potential benefit to patients with EGPA.
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Annals of the Rheumatic Diseases
volume
75
issue
2
pages
396 - 401
publisher
BMJ Publishing Group
external identifiers
  • pmid:25467294
  • wos:000368955700012
  • scopus:84954165832
  • pmid:25467294
ISSN
1468-2060
DOI
10.1136/annrheumdis-2014-206095
language
English
LU publication?
yes
id
abc3607b-795a-4ad9-bb13-f789763b521a (old id 4912811)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25467294?dopt=Abstract
date added to LUP
2016-04-01 10:27:04
date last changed
2022-04-27 22:03:03
@article{abc3607b-795a-4ad9-bb13-f789763b521a,
  abstract     = {{Conventional treatment of eosinophilic granulomatosis with polyangiitis (EGPA) (Churg-Strauss) with glucocorticoids, with or without additional immunosuppressive drugs, is limited by partial efficacy, frequent toxicity and a high relapse rate. Rituximab is a licensed treatment for granulomatosis with polyangiitis and microscopic polyangiitis and is of potential benefit to patients with EGPA.}},
  author       = {{Mohammad, Aladdin and Hot, A and Arndt, F and Moosig, F and Guerry, M-J and Amudala, N and Smith, R and Sivasothy, P and Guillevin, L and Merkel, P A and Jayne, D R W}},
  issn         = {{1468-2060}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{396--401}},
  publisher    = {{BMJ Publishing Group}},
  series       = {{Annals of the Rheumatic Diseases}},
  title        = {{Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).}},
  url          = {{http://dx.doi.org/10.1136/annrheumdis-2014-206095}},
  doi          = {{10.1136/annrheumdis-2014-206095}},
  volume       = {{75}},
  year         = {{2016}},
}